Genistein effect on cognition in prodromal Alzheimer’s disease patients. The GENIAL clinical trial
Abstract Background Delaying the transition from minimal cognitive impairment to Alzheimer’s dementia is a major concern in Alzheimer’s disease (AD) therapeutics. Pathological signs of AD occur years before the onset of clinical dementia. Thus, long-term therapeutic approaches, with safe, minimally...
Main Authors: | José Viña, Joaquín Escudero, Miquel Baquero, Mónica Cebrián, Juan Antonio Carbonell-Asíns, José Enrique Muñoz, Encarnación Satorres, Juan Carlos Meléndez, José Ferrer-Rebolleda, Mª del Puig Cózar-Santiago, Jose Manuel Santabárbara-Gómez, Mariona Jové, Reinald Pamplona, Francisco José Tarazona-Santabalbina, Consuelo Borrás |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-11-01
|
Series: | Alzheimer’s Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13195-022-01097-2 |
Similar Items
-
Neuronal Networks and Continuous Spikes and Waves During Slow Sleep
by: J Gordon Millichap
Published: (2010-11-01) -
The Role of Genistein in Mammalian Reproduction
by: Gabriella Guelfi, et al.
Published: (2023-11-01) -
Monetary Reward and Punishment to Response Inhibition Modulate Activation and Synchronization Within the Inhibitory Brain Network
by: Rupesh K. Chikara, et al.
Published: (2018-03-01) -
Evaluation of Genistein as a Mitochondrial Modulator and Its Effects on Sperm Quality
by: Marilia Ferigolo, et al.
Published: (2023-09-01) -
Neural Basis of Dispositional Awe
by: Fang Guan, et al.
Published: (2018-09-01)